Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Linda Tran

Obstetrics & Gynecology Las Vegas, NV Medical Doctor

NPI 1053705046 CMS profile 7193835

8906 Spanish Ridge Ave Ste 202, Las Vegas, NV 89148

Open in the dashboard

General payments

$71,654

100 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Linda Tran of Las Vegas, NV is reported in the CMS Open Payments database as having received $71,654 across 100 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $48,458 48
2024 General $22,868 36
2022 General $13 1
2020 General $230 12
2019 General $85 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Linda Tran
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Linda Tran were reported at $48,458. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Linda Tran Obstetrics & Gynecology median Middle half National median
2019 $85 $172 $62–$391 $163
2020 $230 $94 $36–$222 $114
2021 $0 $136 $42–$369 $132
2022 $13 $160 $50–$433 $149
2023 $0 $169 $56–$423 $160
2024 $22,868 $152 $50–$371 $164
2025 $48,458 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organon LLC $71,326 84 payments
  2. Merck Sharp & Dohme Corporation $52 2 payments
  3. AbbVie, Inc. $46 2 payments
  4. Daiichi Sankyo Inc. $45 2 payments
  5. Avion Pharmaceuticals $42 2 payments
  6. Vermillion, Inc. $23 1 payment
  7. Vertical Pharmaceuticals, LLC $22 1 payment
  8. Minerva Surgical, Inc $21 1 payment
  9. Exeltis, USA Inc. $19 1 payment
  10. TherapeuticsMD, Inc. $16 1 payment
  11. Other $41 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $42,955 37 payments
  2. Honoraria $20,228 8 payments
  3. Travel and Lodging $4,109 17 payments
  4. Food and Beverage $2,208 35 payments
  5. Consulting Fee $2,140 2 payments
  6. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. JADA SYSTEM $67,971 77 payments
  2. NEXPLANON Etonogestrel $2,140 2 payments
  3. NEXPLANON Womens Health $52 2 payments
  4. ORILISSA $46 2 payments
  5. INJECTAFER $45 2 payments
  6. Balcoltra $42 2 payments
  7. OVA1 $23 1 payment
  8. DIVIGEL $22 1 payment
  9. Symphion $21 1 payment
  10. Genesys HTA $21 1 payment
  11. Other $157 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

100 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Nevada

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record